D.A. Davidson & Co.
- SEC CIK
- 0001080107
- Latest filing
- Jul 24, 2026
GH holding history
Guardant Health, Inc. in every 13F filed by D.A. Davidson & Co., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
GH overviewAll 13F holders of GHFull Q2 2026 holdings
- Shares (Q2 2026)
- 12,526
- Value
- $1.88M
- % of portfolio
- <0.1%
- Quarters held
- 21
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 12,526 | $1.88M | <0.1% | −18,192−59.2% | Reduced | Holders |
| Q1 2026 | 30,718 | $2.84M | <0.1% | +12,866+72.1% | Added | Holders |
| Q4 2025 | 17,852 | $1.82M | <0.1% | +2,005+12.7% | Added | Holders |
| Q3 2025 | 15,847 | $990.1K | <0.1% | −23,466−59.7% | Reduced | Holders |
| Q2 2025 | 39,313 | $2.05M | <0.1% | +15,644+66.1% | Added | Holders |
| Q1 2025 | 23,669 | $1.01M | <0.1% | −18,711−44.2% | Reduced | Holders |
| Q4 2024 | 42,380 | $1.29M | <0.1% | +17,755+72.1% | Added | Holders |
| Q3 2024 | 24,625 | $564.9K | <0.1% | −1,920−7.2% | Reduced | Holders |
| Q2 2024 | 26,545 | $766.6K | <0.1% | −1,150−4.2% | Reduced | Holders |
| Q1 2024 | 27,695 | $571.3K | <0.1% | −2,098−7.0% | Reduced | Holders |
| Q4 2023 | 29,793 | $805.9K | <0.1% | +5,568+23.0% | Added | Holders |
| Q3 2023 | 24,225 | $718.0K | <0.1% | +2,630+12.2% | Added | Holders |
| Q2 2023 | 21,595 | $773.1K | <0.1% | +10,426+93.3% | Added | Holders |
| Q1 2023 | 11,169 | $261.8K | <0.1% | +11,169 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −6,908−100.0% | Sold out | Holders |
| Q3 2022 | 6,908 | $372.0K | <0.1% | +764+12.4% | Added | Holders |
| Q2 2022 | 6,144 | $248.0K | <0.1% | +364+6.3% | Added | Holders |
| Q1 2022 | 5,780 | $383.0K | <0.1% | +602+11.6% | Added | Holders |
| Q4 2021 | 5,178 | $518.0K | <0.1% | +318+6.5% | Added | Holders |
| Q3 2021 | 4,860 | $608.0K | <0.1% | +348+7.7% | Added | Holders |
| Q2 2021 | 4,512 | $560.0K | <0.1% | +240+5.6% | Added | Holders |
| Q1 2021 | 4,272 | $652.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.